http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33073691

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Journal Article|Multicenter Study|Research Support, N.I.H., Extramural
issn 1471-2407
issueIdentifier 1
pageRange 195-
publicationName BMC Cancer
startingPage 195
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_493097e6df5cfad1eb1ed881ab3b7eda
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fd14cd440868f303e0ad5786d20658b9
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_111f1b6e0633f44904ff6b8dcef97de6
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f44e02fcf9fa27484f2fa88838529c69
bibliographicCitation Yang L, Alyasova A, Ye D, Ridolfi A, Dezzani L, Motzer RJ. RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis. BMC Cancer. 2018 Feb 17;18(1):195. PMID: 29454306; PMCID: PMC5816475.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c40582c00c799f59e9f8c5189c909bac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7140972c81d3f9532aad6fa54aa17348
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44f7c004c8c48fb102aee06ae8c02dd7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9128b162def9bb11b05796176d6e447c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_710a9d5faef096bc3c2728d2740e72ee
date 2018-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/29454306
https://pubmed.ncbi.nlm.nih.gov/PMC5816475
https://doi.org/10.1186/s12885-018-4091-5
isPartOf https://portal.issn.org/resource/ISSN/1471-2407
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis
discusses http://id.nlm.nih.gov/mesh/M000602394
http://id.nlm.nih.gov/mesh/M0001483
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10113978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6442177
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329102

Total number of triples: 38.